Premium
Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model
Author(s) -
Brull Astrid,
Luoemí,
BlancoGrau Albert,
Lucia Alejandro,
Martin Miguel Angel,
Arenas Joaquin,
Martí Ramon,
Andreu Antoni L,
Pinós Tomàs
Publication year - 2015
Publication title -
the journal of physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.802
H-Index - 240
eISSN - 1469-7793
pISSN - 0022-3751
DOI - 10.1113/jp270085
Subject(s) - glycogen phosphorylase , glycogen , glycolysis , medicine , glycogen debranching enzyme , endocrinology , glycogen branching enzyme , oxidative phosphorylation , exercise intolerance , glycogen synthase , biology , skeletal muscle , chemistry , biochemistry , metabolism , heart failure
Key points This is the first study to analyse the effect of muscle glycogen phosphorylase depletion in metabolically different muscle types. In McArdle mice, muscle glycogen phosphorylase is absent in both oxidative and glycolytic muscles. In McArdle mice, the glycogen debranching enzyme (catabolic) is increased in oxidative muscles, whereas the glycogen branching enzyme (anabolic) is increased in glycolytic muscles. In McArdle mice, total glycogen synthase is decreased in both oxidative and glycolytic muscles, whereas the phosphorylated inactive form of the enzyme is increased in both oxidative and glycolytic enzymes. In McArdle mice, glycogen content is higher in glycolytic muscles than in oxidative muscles. Additionally, in all muscles analysed, the glycogen content is higher in males than in females. The maximal endurance capacity of the McArdle mice is significantly lower compared to heterozygous and wild‐type mice.Abstract McArdle disease, caused by inherited deficiency of the enzyme muscle glycogen phosphorylase (GP‐MM), is arguably the paradigm of exercise intolerance. The recent knock‐in (p .R50X/p.R50X ) mouse disease model allows an investigation of the phenotypic consequences of muscle glycogen unavailability and the physiopathology of exercise intolerance. We analysed, in 2‐month‐old mice [wild‐type ( wt/wt ), heterozygous ( p.R50X/wt ) and p.R50X/p.R50X )], maximal endurance exercise capacity and the molecular consequences of an absence of GP‐MM in the main glycogen metabolism regulatory enzymes: glycogen synthase, glycogen branching enzyme and glycogen debranching enzyme, as well as glycogen content in slow‐twitch ( soleus ), intermediate ( gastrocnemius ) and glycolytic/fast‐twitch ( extensor digitorum longus ; EDL ) muscles. Compared with wt/wt , exercise capacity (measured in a treadmill test) was impaired in p.R50X/p.R50X (∼48%) and p.R50X/wt mice (∼18%). p.R50X/p.R50X mice showed an absence of GP‐MM in the three muscles. GP‐MM was reduced in p.R50X/wt mice, especially in the soleus , suggesting that the function of ‘slow‐twitch’ muscles is less dependent on glycogen catabolism. p.R50X/p.R50X mice showed increased glycogen debranching enzyme in the soleus , increased glycogen branching enzyme in the gastrocnemius and EDL , as well as reduced levels of mucle glycogen synthase protein in the three muscles (mean ∼70%), reflecting a protective mechanism for preventing deleterious glycogen accumulation. Additionally, glycogen content was highest in the EDL of p.R50X/p.R50X mice. Amongst other findings, the present study shows that the expression of the main muscle glycogen regulatory enzymes differs depending on the muscle phenotype (slow‐ vs . fast‐twitch) and that even partial GP‐MM deficiency affects maximal endurance capacity. Our knock‐in model might help to provide insights into the importance of glycogen on muscle function.